Laidlaw & Company

Laidlaw & Company, founded in 1842, is a New York-based, full-service investment banking and brokerage firm. It offers personalized investment advice and execution services to a diverse range of clients, including private and public institutions, as well as high-net-worth individuals. The firm specializes in various sectors, with a notable focus on healthcare, biotechnology, and pharmaceuticals. Additionally, Laidlaw & Company provides comprehensive wealth management services through its subsidiary, Laidlaw Wealth Management, which offers financial planning, insurance, investment, portfolio management, and risk management services. The firm's venture capital arm, Laidlaw Venture Partners, focuses on growth capital investments in healthcare technologies, supporting businesses at various stages of development.

James Ahern

Managing Partner, Head of Capital Markets

1 past transactions

Algorithm Sciences

Series B in 2021
Algorithm Sciences is a biopharmaceutical company dedicated to optimizing treatments for rare cardiovascular diseases, particularly pulmonary arterial hypertension (PAH). The company develops innovative tools and technologies aimed at enhancing prostacyclin therapy, which is crucial for improving patient outcomes in managing these conditions. By focusing on advanced therapeutic solutions, Algorithm Sciences seeks to provide patients with more effective treatment options, ultimately contributing to better health and quality of life for those affected by cardiovascular disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.